use of the FilmArray GI Panel after the samples were held for 24 h at room temperature (RT) and the results were compared to the original (0-h) results.
Of 103 patients, 33 (32%) had no pathogen detected and 70 (68%) were positive for 81 and 82 pathogens from the SC and FS protocols, respectively ( Table 1 ). The most commonly detected pathogens included C. difficile (n ϭ 31 for SC and 33 for FS), norovirus GI/GII (n ϭ 17 SC and FC), and enteropathogenic Escherichia coli (EPEC) (n ϭ 9 SC and FC). Eight additional pathogens (see Table 1 ) were detected in fewer than 6 samples.
For 33 negative and 67 positive samples, there was complete agreement between the SC and FS testing protocols (overall agreement ϭ 97.1%, 100/103 samples). Three samples had discrepant results; two were positive for C. difficile only when tested using the FS protocol and one was positive for Cryptosporidium only when tested using the SC protocol. The three samples with discrepant results were tested after 24 h of room temperature storage. C. difficile was detected in both samples when tested using the FS and SC protocols (Table 2, samples 9 and 10). Conversely, the FilmArray GI Panel result for Crytosporidium was negative after 24 h of storage using both the SC and FS protocols ( Table 2, sample 25) .
Of the 25 samples tested in the preservation/stability analysis, 20 of the samples processed using the SC protocol and 23 of the samples processed using the FS protocol had concordant results at the 0-h and 24-h time points (Table 2) . Of the samples processed using the SC protocol, 2 were positive at the 0-h time point but negative at the 24-h time point ( [norovirus]). Two of discrepancies were observed in the same samples by both protocols tested (Table 2 , samples 18 and 20). Data files from the five discrepant samples were sent to BioFire Diagnostics for further analysis. In all cases, the discrepant results showed evidence of late amplifications indicating a relatively low pathogen concentration that was below the concentration that was reliably detected by the corresponding FilmArray GI Panel assay. Detection of additional pathogens after extended incubation of the samples could be also explained by organism growth during the storage period; however, Cary-Blair transport medium is designed for the preservation of gastrointestinal pathogens and is not supposed to support organism growth. Studies have indicated that rectal swab specimens (13, 14, 15) , and more recently, Copan FecalSwab specimens (8, 9, 10) can provide accurate test results when used with stool culture and molecular testing of enteric pathogens. Our study results corroborate those of previous studies. Overall, the performances of the 0-h and 24-h FecalSwab specimen PCRs observed in this study were equivalent to those seen using traditional Cary-Blair specimens for detection of GI pathogens using the FilmArray GI Panel on the FilmArray system. The rate of discrepant results observed between the SC and FS procedures was less than 3%. The discordant results were most likely the consequence of a low organism concentration; however, they could also have been caused by weak cross-reactivity and/or contamination during the test process. To conclude, our data support the idea that the FecalSwab system can be used to process raw stool samples prior to testing with the FilmArray GI Panel. Our study, however, did not address the use of the FilmArray GI Panel with rectal swabs. The FecalSwab system optimizes the collection and transport of GI pathogens and rapid diagnosis of gastrointestinal diseases.
